PSEN1 and Alzheimer disease: Dual GLP-1/GIP RA was more effective in reversing memory loss, enhancing synaptic plasticity in the hippocampus, reducing amyloid plaques, and lowering pro-inflammatory cytokine levels in the brain than liraglutide in the APP/PS1 mouse model of AD [222].